HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick P Gleason Selected Research

tocilizumab (atlizumab)

7/2010Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick P Gleason Research Topics

Disease

4Multiple Sclerosis
10/2014 - 11/2007
2Psoriasis (Pustulosis Palmaris et Plantaris)
09/2013 - 07/2010
2Heart Failure
01/2010 - 07/2008
2Myocardial Infarction
05/2009 - 07/2008
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
12/2019
1Hypertension (High Blood Pressure)
09/2016
1Chronic Disease (Chronic Diseases)
09/2013
1Type 2 Diabetes Mellitus (MODY)
04/2012
1Neutropenia
07/2010
1Rheumatoid Arthritis
07/2010
1Psoriatic Arthritis
07/2010
1Thrombocytopenia (Thrombopenia)
07/2010
1Infections
07/2010
1Neoplasms (Cancer)
07/2010
1Transient Ischemic Attack
05/2009
1Hemorrhage
05/2009
1Non-ST Elevated Myocardial Infarction
05/2009
1Stroke (Strokes)
05/2009
1Acute Coronary Syndrome
05/2009
1Myocardial Ischemia (Ischemic Heart Diseases)
07/2008
1Hypoglycemia (Reactive Hypoglycemia)
07/2008
1Chronic Bronchitis
06/2007
1Sinusitis
06/2007
1Pneumonia (Pneumonitis)
06/2007

Drug/Important Bio-Agent (IBA)

3Biological ProductsIBA
10/2014 - 10/2009
2Etanercept (Enbrel)FDA Link
09/2013 - 07/2010
2Insulin (Novolin)FDA Link
04/2012 - 07/2008
2NitratesIBA
04/2012 - 07/2008
2Rosiglitazone (Avandia)FDA Link
04/2012 - 07/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010 - 10/2009
2Tumor Necrosis Factor InhibitorsIBA
07/2010 - 10/2009
1CholesterolIBA
09/2016
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2016
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2016
1phytobacteriomycin (PBM)IBA
09/2016
1Glatiramer Acetate (Copaxone)FDA Link
09/2013
1Infliximab (Remicade)FDA Link
09/2013
1Pharmaceutical PreparationsIBA
09/2013
14-Aminopyridine (4 Aminopyridine)FDA Link
01/2013
1tocilizumab (atlizumab)FDA Link
07/2010
1Ustekinumab (CNTO 1275)FDA Link
07/2010
1LipidsIBA
07/2010
1Cytochrome P-450 CYP3A InhibitorsIBA
01/2010
1Amiodarone (Amiodarona)FDA LinkGeneric
01/2010
1DronedaroneFDA Link
01/2010
1Clopidogrel (Plavix)FDA Link
05/2009
1Prasugrel HydrochlorideFDA Link
05/2009
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2009
12,4-thiazolidinedione (thiazolidinedione)IBA
07/2008
1Interferon beta-1b (Betaseron)FDA Link
11/2007
1telithromycin (Ketek)FDA Link
06/2007

Therapy/Procedure

5Therapeutics
12/2019 - 07/2008
1Drug Therapy (Chemotherapy)
09/2016
1Phototherapy (Light Therapy)
07/2010
1Retreatment
01/2010
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
05/2009
1Duration of Therapy
05/2009
1Contraindications
05/2009
1Percutaneous Coronary Intervention
05/2009
1Stents
07/2008
1Operative Surgical Procedures
07/2008
1Injections
11/2007